— Pulmonary rehabilitation
— Medication Management
— Dietary Management
— Physiotherapy
— Psychological Support
— Social Support
— Education and Self-Management
The multidisciplinary team approach was also applied to an elderly patient experiencing an exacerbation of COPD. Due to advanced age and frail health, managing COPD exacerbations becomes particularly challenging. The patient's respiratory function already compromised by COPD was further strained during the exacerbation, leading to severe dyspnea and increased vulnerability to infections.
— Emergency Room (ER) Doctor
— Pulmonologist
— Respiratory Therapist
— Primary Care Physician
— Nurse
— Pharmacist
— Physical Therapist
— Dietitian
— Psychologist/Psychiatrist
— Social Worker
— Occupational Therapist
A multidisciplinary team (MTD) comprises a group of healthcare professionals proficient in diverse fields. They collaborate as a team to plan, propose, and execute management for complex medical conditions (Chew & Mahadeva, 2018). For this patient, the team members of MTD included the following members;
First, an ER doctor attended the patient who provided him with initial and timely care for the patient's COPD exacerbation. Following this a pulmonologist was consulted who advised labs and made a proper diagnosis. He also directed the treatment plan. The team also included a respiratory therapist who provided crucial support with breathing exercises and oxygen therapy.
Nurses administered the medications and monitored the health status of the patient closely, while pharmacists managed the medications required for symptom relief and management. The team also involved mental health professionals such as psychologists or psychiatrists who addressed any anxiety or depression associated with COPD. Similarly, a primary care physician was also consulted who ensured ongoing care and coordination. A dietitian provided a diet plan considering his age and nutritional requirements.
Additionally, physical therapists were also made the part of multidisciplinary team so that they might provide a customized exercise programs to improve this patient's physical condition and mobility. Social workers were involved so that they might facilitate access to resources and community support in order to ensure a holistic care. This collaborative effort was mainly aimed to manage symptoms effectively, improve the patient's respiratory function, and enhance overall well-being.
Conclusion
— A progressive lung condition requires a comprehensive and multidisciplinary approach
— Severe exacerbation episodes specifies stage 4 disease
— A collaborative effort involving healthcare professionals, patients, and caregivers, promoting lifestyle modifications and adherence to treatment plans is essential.
— Educational initiatives and self-management must be focused.
— Advances in treatment options and ongoing research offer hope for improved management and outcomes.
References
— Abi Abdallah, G., Diop, S., Jamme, M., Legriel, S., & Ferré, A. (2024). Respiratory Infection Triggering Severe Acute Exacerbations of Chronic Obstructive Pulmonary Disease. International journal of chronic obstructive pulmonary disease, 19, 555–565. https://doi.org/10.2147/COPD.S447162
— Bhatt, S. P., Balte, P. P., Schwartz, J. E., Cassano, P. A., Couper, D., Jacobs, D. R., Jr, Kalhan, R., O'Connor, G. T., Yende, S., Sanders, J. L., Umans, J. G., Dransfield, M. T., Chaves, P. H., White, W. B., & Oelsner, E. C. (2019). Discriminative Accuracy of FEV1:FVC Thresholds for COPD-Related Hospitalization and Mortality. JAMA, 321(24), 2438–2447. https://doi.org/10.1001/jama.2019.7233
— Boesing, M., Ottensarendt, N., Lüthi-Corridori, G., & Leuppi, J. D. (2023). The Management of Acute Exacerbations in COPD: A Retrospective Observational Study and Clinical Audit. Journal of clinical medicine, 13(1), 19. https://doi.org/10.3390/jcm13010019
— Chew, J., & Mahadeva, R. (2018). The role of a multidisciplinary severe chronic obstructive pulmonary disease hyperinflation service in patient selection for lung volume reduction. Journal of thoracic disease, 10(Suppl 27), S3335–S3343. https://doi.org/10.21037/jtd.2018.07.36
— Craig, T. J., & Henao, M. P. (2018). Advances in managing COPD related to α1 -antitrypsin deficiency: An under-recognized genetic disorder. Allergy, 73(11), 2110–2121. https://doi.org/10.1111/all.13558
— Currie, G. P., & Douglas, J. G. (2006). Oxygen and inhalers. BMJ (Clinical research ed.), 333(7557), 34–36. https://doi.org/10.1136/bmj.333.7557.34
— Elmenawi, K. A., Anil, V., Gosal, H., Kaur, H., Chakwop Ngassa, H., & Mohammed, L. (2021). The Importance of Measuring Troponin in Chronic Obstructive Pulmonary Disease Exacerbations: A Systematic Review. Cureus, 13(8), e17451. https://doi.org/10.7759/cureus.17451
— Faner, R., Sobradillo, P., Noguera, A., Gomez, C., Cruz, T., López-Giraldo, A., Ballester, E., Soler, N., Arostegui, J. I., Pelegrín, P., Rodriguez-Roisin, R., Yagüe, J., Cosio, B. G., Juan, M., & Agustí, A. (2016). The inflammasome pathway in stable COPD and acute exacerbations. ERJ open research, 2(3), 00002-2016. https://doi.org/10.1183/23120541.00002-2016
— Hikichi, M., Mizumura, K., Maruoka, S., & Gon, Y. (2019). Pathogenesis of chronic obstructive pulmonary disease (COPD) induced by cigarette smoke. Journal of thoracic disease, 11(Suppl 17), S2129–S2140. https://doi.org/10.21037/jtd.2019.10.43
— Kotlyarov S. (2023). The Role of Smoking in the Mechanisms of Development of Chronic Obstructive Pulmonary Disease and Atherosclerosis. International journal of molecular sciences, 24(10), 8725. https://doi.org/10.3390/ijms24108725
— Kukrety, S. P., Parekh, J. D., & Bailey, K. L. (2018). Chronic obstructive pulmonary disease and the hallmarks of aging. Lung India : official organ of Indian Chest Society, 35(4), 321–327. https://doi.org/10.4103/lungindia.lungindia_266_17
— Labaki, W. W., Martinez, C. H., Martinez, F. J., Galbán, C. J., Ross, B. D., Washko, G. R., Barr, R. G., Regan, E. A., Coxson, H. O., Hoffman, E. A., Newell, J. D., Jr, Curran-Everett, D., Hogg, J. C., Crapo, J. D., Lynch, D. A., Kazerooni, E. A., & Han, M. K. (2017). The Role of Chest Computed Tomography in the Evaluation and Management of the Patient with Chronic Obstructive Pulmonary Disease. American journal of respiratory and critical care medicine, 196(11), 1372–1379. https://doi.org/10.1164/rccm.201703-0451PP
— Leap, J., Arshad, O., Cheema, T., & Balaan, M. (2021). Pathophysiology of COPD. Critical care nursing quarterly, 44(1), 2–8. https://doi.org/10.1097/CNQ.0000000000000334
— Love, M. E., & Proud, D. (2022). Respiratory Viral and Bacterial Exacerbations of COPD-The Role of the Airway Epithelium. Cells, 11(9), 1416. https://doi.org/10.3390/cells11091416
— Mansoor, S., Obaida, Z., Ballowe, L., Campbell, A. R., Patrie, J. T., Byrum, T. D., & Shim, Y. M. (2020). Clinical Impact of Multidisciplinary Outpatient Care on Outcomes of Patients with COPD. International journal of chronic obstructive pulmonary disease, 15, 33–42. https://doi.org/10.2147/COPD.S225156
— NICE (2019). Overview: Chronic obstructive pulmonary disease in over 16s: Diagnosis and management: Guidance. NICE. https://www.nice.org.uk/guidance/ng115
— O'Reilly S. (2016). Chronic Obstructive Pulmonary Disease. American journal of lifestyle medicine, 11(4), 296–302. https://doi.org/10.1177/1559827616656593
— Pilcher, J., & Beasley, R. (2015). Acute use of oxygen therapy. Australian prescriber, 38(3), 98–100. https://doi.org/10.18773/austprescr.2015.033
— Rahi, M. S., Thilagar, B., Balaji, S., Prabhakaran, S. Y., Mudgal, M., Rajoo, S., Yella, P. R., Satija, P., Zagorulko, A., & Gunasekaran, K. (2023). The Impact of Anxiety and Depression in Chronic Obstructive Pulmonary Disease. Advances in respiratory medicine, 91(2), 123–134. https://doi.org/10.3390/arm91020011
— Santos, N. C. D., Miravitlles, M., Camelier, A. A., Almeida, V. D. C., Maciel, R. R. B. T., & Camelier, F. W. R. (2022). Prevalence and Impact of Comorbidities in Individuals with Chronic Obstructive Pulmonary Disease: A Systematic Review. Tuberculosis and respiratory diseases, 85(3), 205–220. https://doi.org/10.4046/trd.2021.0179
— Terzikhan, N., Verhamme, K. M., Hofman, A., Stricker, B. H., Brusselle, G. G., & Lahousse, L. (2016). Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam Study. European journal of epidemiology, 31(8), 785–792. https://doi.org/10.1007/s10654-016-0132-z
— Thebault, J. L., Roche, N., Abdoul, H., Lorenzo, A., Similowski, T., & Ghasarossian, C. (2023). Efficacy and safety of oral corticosteroids to treat outpatients with acute exacerbations of COPD in primary care: a multicentre pragmatic randomised controlled study. ERJ open research, 9(5), 00057-2023. https://doi.org/10.1183/23120541.00057-2023
— Wheaton, A. G., Liu, Y., Croft, J. B., VanFrank, B., Croxton, T. L., Punturieri, A., Postow, L., & Greenlund, K. J. (2019). Chronic Obstructive Pulmonary Disease and Smoking Status - United States, 2017. MMWR. Morbidity and mortality weekly report, 68(24), 533–538. https://doi.org/10.15585/mmwr.mm6824a1
0 comments:
Post a Comment